. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Ann Surg Oncol. 2013 Dec 11;21(4):1209–1214. doi: 10.1245/s10434-013-3416-5

Table 2. Univariate analysis of patient and treatment factors, and risk of local recurrence.

Factor	Cumulative Incidence of LR at 60 months (95% confidence interval)	p-value
Margin status ≤ 2 mm	4.7% (0-10.0)	0.11
Margin status > 2 mm	3.7% (1.8-5.5)	0.11
Age at surgery > 50 years	3.8% (1.7-5.8)	0.60
Age at surgery ≤ 50 years	3.9% (0.8-7.0)	0.60
Tumor size > 2 cm	6.4%(2.5-10.3)	0.11
Tumor size ≤ 2 cm	2.6% (0.8-4.3)	0.11
LVI present	4.3% (0.6-8.1)	0.79
LVI absent	3.6% (1.7-5.6)	0.79
Nodal status positive	5.3% (1.4-9.2)	0.65
Nodal status negative	3.2% (1.3-5.1)	0.65
Chemo	4.0% (2.1-5.9)	0.83
No chemo	2.7% (0-6.3)	0.83
Boost	4.3% (2.3-6.4)	0.48
No boost	3.4% (0-10.2)	0.48

LR local recurrence LVI lymphovascular invasion